Strategy that starts with the question that matters:

At APS, we assess your product the way a payer will, then use that perspective to shape the clinical story, value proposition, pricing strategy, contracting approach and engagement plan around it. 

A lot of consultants understand market access.

Our team has helped make the decisions market access strategies are built to influence.

Inside payer expertise

Strategy built by the people who shaped coverage decisions

Access to decision makers

Deep relationships that help turn strategy into action

Clinical + financial accuracy

Connecting product value, payer value and contracting economics

End-to-end market access

One strategic partner from pipeline through lifecycle

Proven access results

Focused on formulary access, market share and sustainable ROI

Our unique three-phase approach BUILDS access strategy through clinical assessment, payer insights, and pricing strategy; EXECUTES through payer engagement, coverage negotiations, and formulary positioning; and OPTIMIZES sustained access through account management, contract renewals, gross-to-net optimization, and performance reviews.

About us

Manufacturers don’t need more theoretical market access advice. They need to know what is likely to happen when their product reaches the payer. Our team combines deep experience from the payer, PBM, clinical, financial and manufacturer sides of the industry to help clients see their product the way the market will see it…and make smarter decisions because of it.

What you see depends on where you’ve sat.

Our payer experts pressure-test the clinical story. Challenge the value proposition. Model payer response. Explore the economics. Identify access risk. And turn those insights into an actionable strategy. 

Better payer insight leads to better decisions. Better decisions create better access strategy.

Payer perspective

Our team has worked inside the organizations and functions responsible for formulary, coverage, clinical policy and contracting decisions.

Clinical + financial thinking

Payers evaluate both. So do we. APS integrates clinical evidence, economic value and contracting implications rather than treating them as separate workstreams.

Strategy + execution

We don’t have to stop when the strategy deck is finished. APS can support payer engagement, PIE and post-launch presentations, contract negotiations, bid activity and ongoing account management.

Candid by design

The goal of payer research isn’t to validate what you already believe. It’s to uncover what could change the outcome.

Relationships with substance

Our long-standing relationships with payer decision-makers help create informed, candid conversations—not simply introductions.

Full-lifecycle perspective

From early pipeline and business development through launch, access and lifecycle management, we see today’s decision in the context of what comes next.

Visibility at every step: APS provides a consistent reporting cadence designed to keep stakeholders informed, aligned, and focused on the actions that drive market access success.

Capabilities

We don’t start with a templated deliverable. We start with the product, the evidence, the economics, the competitive landscape, and the payer decisions standing between where you are and where you need to go. 

Clinical & value assessment

Find the evidence that will matter – and the questions payers are likely to ask.

Pricing & contracting

Know where value can be protected, where flexibility matters and where to draw the line.

Launch & access strategy

Anticipate restrictions, segment the payer landscape and build the route to access before launch.

Payer research & advisory

Get candid answers while there is still time to act on them.

Account management & access execution

Take strategy from the planning room to the payer table.

Lifecycle strategy

Keep access strategy moving as evidence, competition and the market change.

Experience

APS has supported pharmaceutical and biotech clients, ranging from companies preparing for their first product launch to organizations managing global portfolio strategies. 

Our team brings direct experience in clinical policy, P&T decision-making, formulary strategy, PBM contracting, rebate economics, pharmaceutical account management, market access and launch strategy.

0 +

Pharma and biotech clients

0 + years

Industry experience for most of our core team

~ 0 %

Of new business comes through referrals

0 M+

Covered lives represented through our payer market research relationships

Our team


Our professionals have held senior roles across organizations including Medco, Express Scripts, OptumRx, ICER, Ascent Health Services and pharmaceutical manufacturers, giving APS direct operating experience across many of the functions that ultimately shape product access.

Contact us

Please get in touch with any questions, inquiries, or project details and a member of our team will get back to you as soon as possible.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.